|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Estonian Society for Rheumatology |
|---|---|
| Information provided by: | Estonian Society for Rheumatology |
| ClinicalTrials.gov Identifier: | NCT00721318 |
Purpose
The chronic widespread pain (CWP) and fibromyalgia (FM) cause serious discomfort, but at the same time they are not life threatening and they cannot be detected by any laboratory tests. The problems connected with these conditions have gained little attention in Estonia so far. It can be assumed that the CWP and FM often remain undetected and the sufferers live without treatment they need.
So far, there are no data on the prevalence of the CWP and FM in Estonia available.
The goal of the current research is to assess the prevalence of the CWP and local pain syndromes among Estonia's RA patients and among the control population in Tallinn and Harju County; also the factors connected with the presence of the pain and the pain treatment in use.
At the same time there will be a similarly designed research conducted in Jyväskylä Central Hospital, which provides the opportunity to compare results in Estonia's and Finland's research groups. The study on the distribution of the chronic pain among RA patients and control population will allow to assess the magnitude of the problem in Estonia and to raise the awareness of physicians about CWP and significance of its treatment.
Performing the study will provide an experience which forms the base for further epidemiological and clinical research on CWP and FM
| Condition |
|---|
|
Chronic Widespread Pain |
| Study Type: | Observational |
| Study Design: | Case Control, Cross-Sectional |
| Official Title: | A Prevalence Study of Chronic Widespread Pain (CWP) Among Patients With Rheumatoid Arthritis (RA) and Control Population Matched by Gender, Age and Place of Residence in Tallinn and Harjumaa County |
| Estimated Enrollment: | 6000 |
| Study Start Date: | May 2008 |
| Estimated Study Completion Date: | May 2010 |
| Estimated Primary Completion Date: | May 2009 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
1
Patients diagnosed with rheumatoid arthritis
|
|
2
Population controls to the subjects of group 1
|
Eligibility| Ages Eligible for Study: | 16 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study population: Tallinn and Harju County (Estonia), population 552,000. The residents of both Tallinn and Harju County receive national health care services.
2000 RA patients from the East Tallinn Central Hospital's and the North Estonian Regional Hospital's in- and outpatients who live in Tallinn or Harju County
The control sample will be found from the Population Register through matching by gender, age (the same year) and place of residence (living in the city or in the countryside) with the subjects from RA sample according to the official procedure. If required, the research subjects from the control sample will be contacted by a rheumatologist participating in the study.
-
Contacts and Locations More Information
| Responsible Party: | Estonian Society for Rheumatology ( Kati Otsa, MD ) |
| Study ID Numbers: | Merck35016, 35016 |
| Study First Received: | July 22, 2008 |
| Last Updated: | July 23, 2008 |
| ClinicalTrials.gov Identifier: | NCT00721318 |
| Health Authority: | Estonia: The State Agency of Medicine |
|
chronic widespread pain fibromyalgia rheumatoid arthritis Estonia |
|
Autoimmune Diseases Musculoskeletal Diseases Myofascial Pain Syndromes Fibromyalgia Joint Diseases |
Arthritis Connective Tissue Diseases Arthritis, Rheumatoid Pain Rheumatic Diseases |
|
Immune System Diseases |
